<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-House" dms-id="HE33E6BF2364F4460BACA5C5F11B14686" public-private="public" key="H" bill-type="olc"><metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>119 HR 2300 IH: To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes.</dc:title>
<dc:publisher>U.S. House of Representatives</dc:publisher>
<dc:date>2025-03-24</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
<distribution-code display="yes">I</distribution-code><congress display="yes">119th CONGRESS</congress><session display="yes">1st Session</session><legis-num display="yes">H. R. 2300</legis-num><current-chamber>IN THE HOUSE OF REPRESENTATIVES</current-chamber><action display="yes"><action-date date="20250324">March 24, 2025</action-date><action-desc><sponsor name-id="H001086">Mrs. Harshbarger</sponsor> (for herself and <cosponsor name-id="S001190">Mr. Schneider</cosponsor>) introduced the following bill; which was referred to the <committee-name committee-id="HIF00">Committee on Energy and Commerce</committee-name></action-desc></action><legis-type>A BILL</legis-type><official-title display="yes">To ensure national uniformity with respect to certain requirements relating to preterm infant formula, and for other purposes.</official-title></form><legis-body id="H8D6CA4AB99A646509D2F832ABB98C177" style="OLC"><section id="H805CABB14D5C447C8AB27BEED81DF926" section-type="section-one"><enum>1.</enum><header>Preterm infant formula</header><subsection id="HDAA04C1E330C4014BA4C9934B0A4E5F5"><enum>(a)</enum><header>Study</header><paragraph id="H4B5AE78AA703481FB77DFC442D2185B5"><enum>(1)</enum><header>In general</header><text>The Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall study—</text><subparagraph id="H64934A3CB2604D9A8EE79988320CE463"><enum>(A)</enum><text>the availability of preterm infant formula in the United States; </text></subparagraph><subparagraph id="H590590FAF7C443E7A83515B0A15775EB"><enum>(B)</enum><text display-inline="yes-display-inline">Federal and State laws, regulations, orders, and requirements, including under State common law, that relate to preterm infant formula, including with respect to—</text><clause id="H84A60366B933454699ED202CE445D690"><enum>(i)</enum><text>the design, development, clinical testing or investigation, formulation, manufacture, distribution, sale, donation, purchase, marketing, promotion, packaging, labeling, licensing, and use of preterm infant formula; or</text></clause><clause id="H68303F9C6DE048498E7EF8C53B536624"><enum>(ii)</enum><text>any aspect of the safety of preterm infant formula;</text></clause></subparagraph><subparagraph id="HE0EED4F4589A402593BBFAFB63C6D82A"><enum>(C)</enum><text display-inline="yes-display-inline">whether the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/301">21 U.S.C. 301 et seq.</external-xref>) should be amended to require a manufacturer of preterm infant formula to obtain premarket approval for such formula from the Food and Drug Administration; and</text></subparagraph><subparagraph id="H007505A2EF0B48ACAE9D362725E604F8"><enum>(D)</enum><text display-inline="yes-display-inline">if the Secretary recommends such premarket approval, a process and corresponding requirements for such premarket approval.</text></subparagraph></paragraph><paragraph id="H45651EBDDF5F4B2894A3808760591B0F"><enum>(2)</enum><header>Recommendations</header><text display-inline="yes-display-inline">Not later than two years after the date of enactment of this Act, the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, shall submit to the Congress a report on the results of the study under paragraph (1).</text></paragraph></subsection><subsection id="HCA5E8F598C7D438FB03E98709DBFDFFB"><enum>(b)</enum><header>Temporary preemption</header><paragraph id="H2B5B4EAEA7E048D2B76D617F1AA83615"><enum>(1)</enum><header>Period of applicability</header><text display-inline="yes-display-inline">This subsection applies only during the period—</text><subparagraph id="H62AFB98FB563453EA6A7E604EB11DF6F"><enum>(A)</enum><text>beginning on the date of enactment of this Act; and</text></subparagraph><subparagraph id="H7F1EE432B6ED465B87E33BA95E04950B"><enum>(B)</enum><text>ending on the date that is two years after the date of enactment of this Act.</text></subparagraph></paragraph><paragraph id="HD98F454AF4454C2A96B6FDA03018CEAA"><enum>(2)</enum><header>Preemption</header><text>Except as provided in paragraph (3), no State or political subdivision of a State may establish, implement, or enforce with respect to preterm infant formula any requirement, including under any State statute, regulation, order, or common law—</text><subparagraph id="H0B003AFB06BE40BF995D81D18E4C53DE"><enum>(A)</enum><text>that is different from, or in addition to, any requirement applicable to preterm infant formula under the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/301">21 U.S.C. 301 et seq.</external-xref>), the Poison Prevention Packaging Act of 1970 (<external-xref legal-doc="usc" parsable-cite="usc/15/1471">15 U.S.C. 1471 et seq.</external-xref>), or the Fair Packaging and Labeling Act (<external-xref legal-doc="usc" parsable-cite="usc/15/1451">15 U.S.C. 1451 et seq.</external-xref>); and</text></subparagraph><subparagraph id="HDE44D067F9614B999D9C847F20D1ED9E"><enum>(B)</enum><text display-inline="yes-display-inline">that relates to preterm infant formula, including—</text><clause id="H2F6D1958189B484BBBE358C61C638EC7"><enum>(i)</enum><text>the design, development, clinical testing or investigation, formulation, manufacture, distribution, sale, donation, purchase, marketing, promotion, packaging, labeling, licensing, and use of preterm infant formula; and</text></clause><clause id="H660ED6930B7647CEA3DCBBC27B34BCEC"><enum>(ii)</enum><text>any aspect of the safety of preterm infant formula.</text></clause></subparagraph></paragraph><paragraph id="H606C21EF99AC4D188281E540A33FA9D0"><enum>(3)</enum><header>Exception for civil and criminal actions for willful misconduct</header><subparagraph id="H5026C08D9D854B748DE6C4F4385FF304"><enum>(A)</enum><header>Exception</header><text>Paragraph (2) does not preempt civil or criminal actions based on a requirement described in paragraph (2) to the extent such actions are against a manufacturer for willful misconduct in the manufacturing or production of preterm infant formula that caused death or serious physical injury.</text></subparagraph><subparagraph id="H6EF9BFF12AA9446183800C8A8C66F68A"><enum>(B)</enum><header>Removal</header><text>In the case of a civil action brought in a State court against a manufacturer, if that manufacturer alleges that the law under which the action is brought is preempted by paragraph (2), such action may be removed by the manufacturer to the district court of the United States for the district and division embracing the place wherein the civil action is pending. This subparagraph applies to any action pending before, on, or after the date of enactment of this Act, except to the extent that there is a final judgment from which no appeal may be taken and no further review may be sought from a court of last resort, including the Supreme Court of the United States.</text></subparagraph><subparagraph id="H224C53F5194441A28DD9D6C08B4135E6"><enum>(C)</enum><header>Burden of proof</header><text display-inline="yes-display-inline">In determining whether the exception in subparagraph (A) applies, the plaintiff shall have the burden of proving that the criteria described in subparagraph (A) are met by clear and convincing evidence.</text></subparagraph></paragraph><paragraph id="H959B5CF975944A198C5A2D844A63F72B"><enum>(4)</enum><header>Dismissal of pending actions</header><text>A civil or criminal action that is pending as of the date of enactment of this Act shall be dismissed to the extent such action seeks to implement or enforce a requirement that is preempted by paragraph (2).</text></paragraph></subsection><subsection id="HD4916777578F4714B15011C90C611082"><enum>(c)</enum><header>Definitions</header><text>In this section:</text><paragraph id="HFE89A3C0825B4DE48760EA9C65CC60B9"><enum>(1)</enum><text>The term <term>infant formula</term> has the meaning given to such term in section 201(z) of the Federal Food, Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/321">21 U.S.C. 321(z)</external-xref>).</text></paragraph><paragraph id="H403CF23DCA6540F089AF557B91DF941A"><enum>(2)</enum><text>The term <term>manufacturer</term>—</text><subparagraph id="H34150A8EB08D44D8B268CACC83693CC7"><enum>(A)</enum><text>means a person who—</text><clause id="H0A6F8BA7FBF8477FB31A21D6CCFD7801"><enum>(i)</enum><text>prepares, reconstitutes, or otherwise changes the physical or chemical characteristics of a preterm infant formula; or</text></clause><clause id="HA1C6B7C2D95E45F2BEB5475E6AB97118"><enum>(ii)</enum><text>packages or labels a preterm infant formula in a container for distribution; and</text></clause></subparagraph><subparagraph id="H28137E38A700401EA1FC57231199D51D"><enum>(B)</enum><text>does not include a person taking actions described in subparagraph (A) exclusively for an infant under such person’s direct care.</text></subparagraph></paragraph><paragraph id="H9FE979815ADD46FBAE63B0B2E24BC795"><enum>(3)</enum><text>The term <term>preterm infant formula</term> means any infant formula that is exempt under section 412(h)(1) of the Federal Food Drug, and Cosmetic Act (<external-xref legal-doc="usc" parsable-cite="usc/21/350a">21 U.S.C. 350a(h)</external-xref>) and intended to be administered to—</text><subparagraph id="H7034E63F89444435998F96A3A4F9C610"><enum>(A)</enum><text>an infant born before 37 weeks of gestation; or</text></subparagraph><subparagraph id="H3932A43697624CE9A59D6FE91AB9FC04"><enum>(B)</enum><text>a low-birth-weight infant.</text></subparagraph></paragraph><paragraph id="HD8F43965149C47F6AEFCE1E62629DB5A"><enum>(4)</enum><text display-inline="yes-display-inline">The term <term>willful misconduct</term> means, except as such term is further restricted pursuant to subparagraph (B), an act or omission that is taken—</text><subparagraph id="HAF014CFD1C9747979365EF0BCF1F69C2"><enum>(A)</enum><text>intentionally to achieve a wrongful purpose;</text></subparagraph><subparagraph id="H9E9345C33A0548B18D387C0180666246"><enum>(B)</enum><text>knowingly without legal or factual justification; and</text></subparagraph><subparagraph id="H3F2F29AB8B02472792299102A5C1CE91"><enum>(C)</enum><text>in disregard of a known or obvious risk that is so great as to make it highly probable that the harm will outweigh the benefit.</text></subparagraph></paragraph></subsection></section></legis-body></bill> 

